Key facts
- This page summarizes Robert W. Postma's Form 4 filing for Alaunos Therapeutics, Inc. (TCRT).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 01 May 2026, 16:18.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Award
No transaction description listed
No transaction description listed
Additional SEC filing notes
Footnote F1
Represents shares of common stock issued in lieu of board fees.
Footnote F2
The shares are directly held by WaterMill Asset Management Corp. ("WaterMill"). The Reporting Person serves as the principal of WaterMill.